Immunotherapy With IFx-Hu2.0 Vaccine for Advanced MCC or cSCC

Conditions:   Merkel Cell Carcinoma;   Cutaneous Squamous Cell Carcinoma Intervention:   Biological: IFx-Hu2.0 Sponsors:   Morphogenesis, Inc.;   H. Lee Moffitt Cancer Center and Research Institute Recruiting

Source: ClinicalTrials.gov - November 11, 2019 Category: Research Source Type: clinical trials